Ab Science
Clinical trials sponsored by Ab Science, explained in plain language.
-
New hope for tough leukemia? early trial tests AB8939
Disease control Recruiting nowThis early-phase trial is testing a new drug called AB8939, given daily through a vein, for people with acute myeloid leukemia that has come back or not responded to standard treatments. About 78 participants will receive AB8939, sometimes with another drug called venetoclax. The…
Phase: PHASE1, PHASE2 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Hope for ALS patients: new drug combo enters final testing phase
Disease control Recruiting nowThis Phase 3 trial is testing whether adding masitinib to the standard ALS drug riluzole can slow the disease better than riluzole alone. About 495 people with ALS will take either masitinib or a placebo, plus riluzole, and researchers will track changes in muscle function, breat…
Phase: PHASE3 • Sponsor: AB Science • Aim: Disease control
Last updated Jun 26, 2026 16:03 UTC